Janssen Pharmaceutica Products L.P.

News & Analysis

janssen pharmaceutica products l.p. - All News and Analysis

• Eon Labs Begins Shipping Itraconazole Capsules

  - 2005-02-09

  LAKE SUCCESS, N.Y. -- Eon Labs, Inc. (Nasdaq: ELAB) announced today that it began shipping Itraconazole 100mg capsules, the generic equivalent to SporanoxR* capsules. As the first company to file an ANDA with a Paragraph IV patent certification for this product, Eon Labs is entitled to 180 days of market...

  Tags: Eon Labs, Janssen Pharmaceutica Products L.P.

• Confusion over names leads to errors

  - 2004-12-01

  Confusion over the similar names of the dementia drug Reminyl galantamine and the diabetes drug Amaryl glimepiride has resulted in several adverse events, including severe hypoglycemia and one death. According to Janssen Pharmaceutica Products L.P.--the maker of galantamine--prescriptions have been incorrectly written, interpreted, labeled, and/or filled because of the...

  Tags: Janssen Pharmaceutica Products L.P.

• Prescribing errors raise concern at Janssen

  - 2004-11-08

  Janssen Pharmaceutica Products LP has launched a campaign for safe medication dispensing of Reminyl, its drug for treating mild to moderate conditions of Alzheimer's disease. Several reports of errors in prescribing have arisen due to confusion between the product and Amaryl, a diabetes drug marketed by Aventis Pharmaceuticals. Administration of...

  Tags: Janssen Pharmaceutica Products L.P.

• Eon Labs Receives Favorable District Court Ruling on Itraconazole Capsules

  - 2004-07-30

  LAURELTON, N.Y. -- Eon Labs, Inc. (Nasdaq: ELAB) announced today that the U.S. District Court for the Eastern District of New York granted judgment in favor of Eon Labs ruling that, while the validity of the patent was upheld, the Company's Itraconazole 100mg capsules does not infringe Janssen Pharmaceutica N.V....

  Tags: Company, Eon Labs, Janssen Pharmaceutica Products L.P.

• Janssen Pharmaceutica Products, L.P. (Corporate Profile).

  - 2002-11-01

  Janssen at Washington Crossing 1125 Trenton-Harbourton Rd. PO Box 200 Titusville, NJ 08560-0200 Phone: (800) JANSSEN Web: www.janssen.com Janssen Pharmaceutica Products, L.P., is a company driven by a dedication to product innovation, customer focus and employee/organizational excellence. Since its founding in...

  Tags: Janssen Pharmaceutica Products L.P., Johnson & Johnson

• GALANTAMINE HYDROBROMIDE.(Janssen Pharmaceutica Products L.P., Reminyl)(Brief Article)

  - 2001-03-12

  Janssen Pharmaceutica Products, L.P., a wholly owned subsidiary of Johnson & Johnson, has received FDA approval for Reminyl galantamine hydrobromide for treatment of moderate Alzheimer's disease. Reminyl is derived from the bulbs of daffodils.

  Tags: FDA, Janssen Pharmaceutica Products L.P., Johnson & Johnson

• JANSSEN PHARMACEUTICA PRODUCTS.(receives approval letter for Reminyl)(Brief Article)

  - 2000-08-07

  JANSSEN PHARMACEUTICA Products and Shire Pharmaceuticals Group PLC have received an approvable letter from Food and Drug Administration for Reminyl galantamine hydrobromide, used to treat Alzheimer's disease. This follows approval by Switzerland and successful completion of the European mutal recognition program.

  Tags: FDA, Janssen Pharmaceutica Products L.P.